23rd Feb 2024 A plain language summary looking at the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
14th Nov 2023 A plain language summary of the ARROW study: pralsetinib in patients with RET fusion–positive non-small cell lung cancer
12th Apr 2023 Plain Language Summary: Afatinib for the treatment of non-small-cell lung cancer with unusual EGFR mutations